Results 301 to 310 of about 413,499 (385)

Prevalence and prognostic value of different iron deficiency definitions in light chain cardiac amyloidosis patients

ESC Heart Failure, EarlyView.
Non‐scaled Venn diagram of iron deficiency (ID) according to various definitions and associated outcomes. The prevalence of iron deficiency was high, irrespective of the definition applied. ID defined by TSAT <20% or serum iron <13 μmol/L, rather than the guideline definition, was associated with worse outcomes.
Xinqing Li, Anran Xin, Yan Huang, Qiong Zhou, Jinxi Wang, Ping Zhou, Stefan D. Anker, Yuhui Zhang   +7 more
wiley   +1 more source

Multiple cardioembolic attacks with a huge ventricular thrombus in dilated cardiomyopathy: A case report and comprehensive review. [PDF]

J Int Med Res
Moayerifar M, Moayerifar M, Gholipour M, Samidoust P, Poursadrolah S, Ghasemzadeh G, Radmoghadam M.   +6 more
europepmc   +1 more source

An Unusual Pattern of the Mitral Echocardiogram Observed in Cases of Congestive Cardiomyopathy and Other Myocardial Diseases

, 1975
Yasuharu Nimura, Seiki Nagata, Masayuki Matsumoto, Shintaro Beppu, Masahiko Tamai, Yoshio Yamada, Hirohíde Matsuo, Hiroshi Sakakibara, Hiroshi Abe   +8 more
openalex   +2 more sources

Identification of disease-specific pathways and modifiers in phospholamban R14del cardiomyopathy: rationale, design and baseline characteristics of DECIPHER-PLN cohort. [PDF]

Neth Heart J
Deiman FE, de Brouwer R, Baumhove L, Bomer N, Grote Beverborg N, van der Meer P.   +5 more
europepmc   +1 more source

Right ventricular dysfunction for prediction of long‐term recovery in de novo HFrEF : a PROLONG‐II substudy

ESC Heart Failure, EarlyView.
Abstract Aims To analyse the predictive value of advanced markers of right ventricular (RV) function and RV‐pulmonary arterial (PA) coupling in forecasting long‐term left ventricular (LV) improvement in de novo heart failure with reduced ejection fraction (HFrEF).
Aiste Monika Jakstaite, Johanna Mueller‐Leisse, Henrike A.K. Hillmann, Stephan Hohmann, Jörg Eiringhaus, Udo Bavendiek, Tibor Kempf, Christian Veltmann, Johann Bauersachs, David Duncker, D. Berliner   +10 more
wiley   +1 more source

The potential of CRISPR-Cas9 in cardiovascular medicine: a focus on hereditary cardiomyopathies. [PDF]

Ann Med Surg (Lond)
Rasheed S, Jha M, Waheed A, Farooq U, Fatima A, Haq IU, Khan U, Wardak AB, Gul MH.   +8 more
europepmc   +1 more source

Cardiac magnetic resonance left atrioventricular coupling index as a prognostic tool in hypertrophic cardiomyopathy

ESC Heart Failure, EarlyView.
Abstract Aims A novel marker left atrioventricular coupling index (LACI) has been proved to be associated with cardiovascular events in patients without history of cardiovascular disease. However, the studies on cardiac magnetic resonance‐derived LACI in hypertrophic cardiomyopathy (HCM) patients are limited, and the prognostic value of LACI has still ...
Jinyang Wen, Junhao Tu, Xinwei Tao, Yuanyuan Tang, Zhaoxia Yang, Ziyi Pan, Yi Luo, Chunlin Xiang, Dazhong Tang, Lu Huang, Liming Xia   +10 more
wiley   +1 more source

MitraClip combined with PTSBME for the treatment of obstructive hypertrophic cardiomyopathy with severe mitral regurgitation: a case report. [PDF]

J Cardiothorac Surg
Wang X, Liang Z, Liu M, Huang S, Pan G.
europepmc   +1 more source

Immune cell dynamics in heart failure: implicated mechanisms and therapeutic targets

ESC Heart Failure, EarlyView.
Abstract The relationship between heart failure (HF) and immune activation has garnered significant interest. Studies highlight the critical role of inflammation in HF, affecting cardiac structure and function. Despite promising anti‐inflammatory therapies, clinical trials have faced challenges, indicating an incomplete understanding of immune ...
Gen Li, Wu He, Dao Wen Wang
wiley   +1 more source